These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32302655)

  • 1. Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli.
    Lipničanová S; Chmelová D; Godány A; Ondrejovič M; Miertuš S
    J Biotechnol; 2020 Jun; 316():27-34. PubMed ID: 32302655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in
    Lipničanová S; Legerská B; Chmelová D; Ondrejovič M; Miertuš S
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step heating strategy for efficient solubilization of recombinant spider silk protein from inclusion bodies.
    Cai H; Chen G; Yu H; Tang Y; Xiong S; Qi X
    BMC Biotechnol; 2020 Jul; 20(1):37. PubMed ID: 32650749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli.
    Khan RH; Rao KB; Eshwari AN; Totey SM; Panda AK
    Biotechnol Prog; 1998; 14(5):722-8. PubMed ID: 9758661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
    Sharma R; Anupa A; Rathore AS
    Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
    Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
    Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
    Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
    Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Solubilization and Refolding Buffers.
    Roufarshbaf M; Akbari V
    Methods Mol Biol; 2023; 2617():155-164. PubMed ID: 36656522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
    Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
    Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
    Upadhyay V; Singh A; Panda AK
    Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid method for an enhanced recovery of biologically active human phospholipid scramblase1 from inclusion bodies.
    Palanirajan SK; Gummadi SN
    Anal Biochem; 2018 Sep; 556():104-111. PubMed ID: 29964029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, refolding and purification of a human interleukin-17A variant.
    Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
    Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
    Bu D; Zhou Y; Tang J; Jing F; Zhang W
    Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a recombinant Bacteroides fragilis sialidase expressed in Escherichia coli.
    Yamamoto T; Ugai H; Nakayama-Imaohji H; Tada A; Elahi M; Houchi H; Kuwahara T
    Anaerobe; 2018 Apr; 50():69-75. PubMed ID: 29432848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.